NuGen Medical Devices Inc (NGMD) - Net Assets
Based on the latest financial reports, NuGen Medical Devices Inc (NGMD) has net assets worth CA$-13.74 Million CAD (≈ $-9.94 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$4.29 Million ≈ $3.10 Million USD) and total liabilities (CA$18.03 Million ≈ $13.04 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check NuGen Medical Devices Inc (NGMD) tangible net worth to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$-13.74 Million |
| % of Total Assets | -320.03% |
| Annual Growth Rate | N/A |
| 5-Year Change | -928.48% |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
NuGen Medical Devices Inc - Net Assets Trend (2020–2025)
This chart illustrates how NuGen Medical Devices Inc's net assets have evolved over time, based on quarterly financial data. See NGMD days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for NuGen Medical Devices Inc (2020–2025)
The table below shows the annual net assets of NuGen Medical Devices Inc from 2020 to 2025. For live valuation and market cap data, see NuGen Medical Devices Inc market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CA$-13.74 Million ≈ $-9.94 Million |
-142.17% |
| 2024-12-31 | CA$-5.67 Million ≈ $-4.10 Million |
-175.29% |
| 2023-12-31 | CA$-2.06 Million ≈ $-1.49 Million |
+8.94% |
| 2022-12-31 | CA$-2.26 Million ≈ $-1.64 Million |
-236.47% |
| 2021-12-31 | CA$1.66 Million ≈ $1.20 Million |
+339.49% |
| 2020-12-31 | CA$-692.25K ≈ $-500.76K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to NuGen Medical Devices Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3212580000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CA$27.10 Million | % |
| Total Equity | CA$-13.74 Million | 100.00% |
NuGen Medical Devices Inc Competitors by Market Cap
The table below lists competitors of NuGen Medical Devices Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Eagle Pharmaceuticals Inc
NASDAQ:EGRX
|
$3.29 Million |
|
Harris Technology Group Ltd
AU:HT8
|
$3.29 Million |
|
Marvel Discovery Corp
V:MARV
|
$3.29 Million |
|
Albion Enterprise VCT PLC
LSE:AAEV
|
$3.29 Million |
|
New Zealand Coastal Seafoods Ltd
AU:NZS
|
$3.28 Million |
|
Krida Jaringan Nusantara Tbk PT
JK:KJEN
|
$3.28 Million |
|
RPM Automotive Group Ltd
AU:RPM
|
$3.28 Million |
|
Pembroke VCT PLC
LSE:PEMB
|
$3.28 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NuGen Medical Devices Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -5,671,659 to -13,735,100, a change of -8,063,441.
- Net loss of 7,826,168 reduced equity.
- Other factors decreased equity by 237,273.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$-7.83 Million | -56.98% |
| Other Changes | CA$-237.27K | -1.73% |
| Total Change | CA$- | % |
Book Value vs Market Value Analysis
This analysis compares NuGen Medical Devices Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | CA$-0.01 | CA$0.02 | x |
| 2021-12-31 | CA$0.02 | CA$0.02 | x |
| 2022-12-31 | CA$-0.02 | CA$0.02 | x |
| 2023-12-31 | CA$-0.01 | CA$0.02 | x |
| 2024-12-31 | CA$-0.03 | CA$0.02 | x |
| 2025-12-31 | CA$-0.06 | CA$0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently NuGen Medical Devices Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3034.00%
- • Asset Turnover: 0.06x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-71.45%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 0.00% | -7760.66% | 0.00x | 0.00x | CA$-3.60 Million |
| 2021 | -428.69% | -5163.23% | 0.02x | 5.34x | CA$-7.27 Million |
| 2022 | 0.00% | -3661.07% | 0.02x | 0.00x | CA$-5.35 Million |
| 2023 | 0.00% | -2825.02% | 0.05x | 0.00x | CA$-9.16 Million |
| 2024 | 0.00% | -517.47% | 0.08x | 0.00x | CA$-4.66 Million |
| 2025 | 0.00% | -3034.00% | 0.06x | 0.00x | CA$-6.45 Million |
Industry Comparison
This section compares NuGen Medical Devices Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $8,022,698
- Average return on equity (ROE) among peers: -17.74%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NuGen Medical Devices Inc (NGMD) | CA$-13.74 Million | 0.00% | N/A | $3.28 Million |
| Aurora Spine Corp (ASG) | $3.81 Million | -19.18% | 1.73x | $12.99 Million |
| MedX Health Corp (MDX) | $-2.39 Million | 0.00% | 0.00x | $11.86 Million |
| Perimeter Medical Imaging AI Inc (PINK) | $26.11 Million | -13.74% | 0.33x | $27.98 Million |
| Profound Medical Corp (PRN) | $31.18 Million | -91.63% | 0.41x | $253.09 Million |
| Therma Bright Inc (THRM) | $-3.54 Million | 0.00% | 0.00x | $2.10 Million |
| Theralase Technologies Inc. (TLT) | $3.39 Million | 0.38% | 0.05x | $49.19 Million |
| VentriPoint Diagnostics Ltd (VPT) | $-2.40 Million | 0.00% | 0.00x | $16.97 Million |
About NuGen Medical Devices Inc
NuGen Medical Devices Inc., a specialty medical device company, engages in developing and commercializing novel drug delivery technologies in Europe, Asia, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, vaccines, veterinary, home healthcare, and others. It also provides Ins… Read more